The central administration of a GLP-1R antagonist blocks the plasma increase of ACTH and corticosterone induced by the EPM and decreases anxiety-like behaviors in the EPM, indicating that central nervous system (CNS) GLP-1 mediates anxiety responses [120]. This evidence concerns the gene GLP1R and Anxiety.